1.Quality of Acute Stroke Care within Emergency Medical Service System in Korea: Proposal for Severe Emergency Medical Center
Kyung Bok LEE ; Ji Sung LEE ; Jeong-Yoon LEE ; Jun Yup KIM ; Han-Yeong JEONG ; Seong-Eun KIM ; Jonguk KIM ; Do Yeon KIM ; Keon-Joo LEE ; Jihoon KANG ; Beom Joon KIM ; Tae Jung KIM ; Sang Joon AN ; Jang-Hyun BAEK ; Seongheon KIM ; Hyun-Wook NAH ; Jong Yun LEE, ; Jee-Hyun KWON ; Seong Hwan AHN ; Keun-Hwa JUNG ; Hee-Kwon PARK ; Tai Hwan PARK ; Jong-Moo PARK ; Yong-Jin CHO ; Im Seok KOH ; Soo Joo LEE ; Jae-Kwan CHA ; Joung-Ho RHA ; Juneyoung LEE ; Boung Chul LEE ; In Ok BAE ; Gui Ok KIM ; Hee-Joon BAE
Journal of the Korean Neurological Association 2023;41(1):18-30
Background:
Korea recently established 70 emergency medical service areas. However, there are many concerns that medical resources for stroke could not be evenly distributed through the country. We aimed to compare the treatment quality and outcomes of acute stroke among the emergency medical service areas.
Methods:
This study analyzed the data of 28,800 patients admitted in 248 hospitals which participated in the 8th acute stroke quality assessment by Health Insurance Review and Assessment Service. Individual hospitals were regrouped into emergency service areas according to the address of the location. Assessment indicators and fatality were compared by the service areas. We defined the appropriate hospital by the performance of intravenous thrombolysis.
Results:
In seven service areas, there were no hospitals which received more than 10 stroke patients for 6 months. In nine service areas, there were no patients who underwent intravenous thrombolysis (IVT). Among 167 designated emergency medical centers, 50 hospitals (29.9%) responded that IVT was impossible 24 hours a day. There are 97 (39.1%) hospitals that meet the definitions of appropriate hospital. In 23 service areas (32.9%) had no appropriate or feasible hospitals. The fatality of service areas with stroke centers were 6.9% within 30 days and 15.6% within 1 year from stroke onset than those without stroke centers (7.7%, 16.9%, respectively).
Conclusions
There was a wide regional gap in the medical resource and the quality of treatments for acute stroke among emergency medical service areas in Korea. The poststroke fatality rate of the service areas which have stroke centers or appropriate hospitals were significantly low.
2.Outcome of cardiopulmonary resuscitation for prehospital traumaticcardiac arrest: focused on Gangwon province
Chang Woo IM ; Taehun LEE ; Taek Geun OHK ; Oh Hyun KIM ; Sang Ku JUNG ; Yunsung KIM ; Bum Sug MA ; Moo Eob AHN ; Jeong Yeol SEO ; Dong Won KIM
Journal of the Korean Society of Emergency Medicine 2020;31(2):135-145
Objective:
This aim examined the outcomes of resuscitation and the clinical characteristics of patients with pre-hospitaltraumatic cardiac arrests (TCA).
Methods:
The charts of patients with pre-hospital TCA who visited the various emergency department (ED) in Gangwondofrom January 2013 to December 2017 were reviewed retrospectively.
Results:
TCA patients comprised 0.3% of patients transferred by 119. A total of 367 patients were enrolled in the study.Traffic accidents were the leading cause of the arrest. The initial field and ED rhythm were mostly asystole (field, 79.6%;ED, 82.3%). It took 11.24±9.95 minutes from the call to the field. From the field to ED, it took 22.87±15.37 minutes. Thetotal CPR time before ED arrival was 21.62±15.29 minutes. The causes of TCA were brain injury (35.7%), hypovolemicshock (29.2%), and severe lung injury (16.3%). Seventy TCA patients experienced at least one return of spontaneous circulation(ROSC). Twenty-six patients (7.14%) were admitted to the ward, and their average injury severity score was38.96. Eight patients expired before 12 hours after transient ROSC. Four more patients expired before 24 hours. Fourpatients were discharged alive among patients who lived for more than 24 hours.
Conclusion
In this study, 1.5% of patients were discharged alive. The possibility of ROSC was higher as the time to ED,and the cardiopulmonary resuscitation time of 119 was shorter. Pulseless electrical activity rather than asystole tends topromote ROSC. The survival rate increased when ROSC occurred before arriving at the ED.
3.Multicenter Adherence Study of Asthma Medication for Children in Korea
Chang Keun KIM ; Zak CALLAWAY ; Jungi CHOI ; Hyo Bin KIM ; Eun Mi KWON ; Yoon Seok CHANG ; Yeong Ho RHA ; Soo Jong HONG ; Jae Won OH ; Hyun Hee KIM ; Dae Hyun LIM ; Sung Won KIM ; Kang Seo PARK ; Yong Hoon CHO ; Hai Lee CHUNG ; Hee Ju PARK ; Sang Gun JUNG ; Im Joo KANG ; Myung Chul HYUN ; Moo Young OH ; Jin A JUNG ; Myung Sung KIM ; Jung Yeon SHIM ; Jin Tack KIM ; Young Yull KOH ;
Allergy, Asthma & Immunology Research 2019;11(2):222-230
PURPOSE: Adherence is a major component of successful medical treatment. However, non-adherence remains a barrier to effective delivery of healthcare worldwide. METHODS: Twenty healthcare facilities (secondary or tertiary hospitals) belonging to the Korean Academy of Pediatric Allergy and Respiratory Diseases (KAPARD) participated. Questionnaires were given to patients currently receiving treatment in the form of inhalant useor oral intake or transdermal patch for mild to moderate asthma. RESULTS: A total of 1,838 patients responded to the questionnaire. Mean age was 5.98 ± 3.79 years (range: 0-18 years). With help from their caregivers, the percentage of patients that answered “taking as prescribed” was 38.04% for inhalant users, 50.09% for oral medication users and 67.42% for transdermal users. Transdermal patch users had significantly greater adherence compared to the other 2 groups (P < 0.001). The 34.15% of inhalant users, 70.33% of oral medication users and 93.00% of transdermal patch users felt that their medication delivery system was “Easy” or “Very easy” to use (P < 0.001). “Method of administration” was deemed to be the most difficult part of the treatment regimen to follow, and 76.7% of patients preferred once-daily administration (i.e., “Frequency of administration”). CONCLUSIONS: Asthma medication adherence in young children was found to be better in the transdermal patch group. This may be due to requiring fewer doses and easy to follow instructions. From an adherence point of view, the transdermal patch seems more useful for long-term asthma control in children compared to oral or inhaled medicine.
Asthma
;
Caregivers
;
Child
;
Delivery of Health Care
;
Humans
;
Hypersensitivity
;
Korea
;
Medication Adherence
;
Transdermal Patch
4.A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Results of the Korean South West Oncolog.
So Yeon JEON ; Hye Sook HAN ; Woo Kyun BAE ; Moo Rim PARK ; Hyeok SHIM ; Sang Cheol LEE ; Se Il GO ; Hwan Jung YUN ; Yong Jin IM ; Eun Kee SONG
Cancer Research and Treatment 2019;51(1):90-97
PURPOSE: Data on the efficacy of olanzapine in patients receiving moderately emetogenic chemotherapy (MEC) are limited. This study aimed to evaluate and compare the efficacy of olanzapine versus placebo in controlling nausea and vomiting in patients receiving MEC. MATERIALS AND METHODS: We conducted a randomized, double-blind, placebo-controlled study to determine whether olanzapine can reduce the frequency of chemotherapy-induced nausea and vomiting (CINV) and improve the quality of life (QOL) in patients receiving palonosetron and dexamethasone as prophylaxis for MEC-induced nausea and vomiting. The primary end point was complete response for the acute phase (0-24 hours after chemotherapy). The secondary end points were complete response for the delayed (24-120 hours) and overall phase (0-120 hours), proportion of significant nausea (visual analogue scale ≥ 25 mm), use ofrescue medications, and effect on QOL. RESULTS: Fifty-six patients were randomized to the olanzapine (n=29) and placebo (n=27) groups. Complete response rates were not significantly different between the olanzapine and placebo groups in the acute (96.5% vs. 88.0%, p=0.326), delayed (69.0% vs. 48.0%, p=0.118), and overall phases (69.0% vs. 48.0%, p=0.118). However, the percentage of patients with significant nausea (17.2% vs. 44.0%, p=0.032) and the use of rescue medications (0.03±0.19 vs. 1.88±2.88, p=0.002) were lower in the olanzapine group than in the placebo. Furthermore, the olanzapine group demonstrated better QOL (p=0.015). CONCLUSION: Olanzapine combined with palonosetron and dexamethasone significantly improved QOL and vomiting control among previously untreated patients receiving MEC, although the efficacy was limited to the reduction of the frequency of CINV.
Antiemetics
;
Dexamethasone
;
Drug Therapy*
;
Humans
;
Nausea*
;
Quality of Life
;
Vomiting*
5.Two Cases of Radiologically Isolated Syndrome: First Case Report in Korea
Kayeong IM ; Jun Sang SUNWOO ; Kyum Yil KWON ; Kyung Bok LEE ; Moo Young AHN ; Hakjae ROH
Soonchunhyang Medical Science 2019;25(1):65-68
With increasing sensitivity, availability, and use of magnetic resonance imaging (MRI) in the past three decades, there is also an increase in incidental abnormal findings. The most common findings of these incidental abnormalities are white matter lesions that are interpreted as demyelinating based on radiological criteria. MRI findings suggestive of multiple sclerosis (MS) in patients without typical MS symptoms and with normal neurologic findings are now defined as a radiologically isolated syndrome (RIS) which reported relatively low incidence, especially hard to find case report in Korea. The natural history and pathophysiologic processes of RIS remain largely unknown. The nature, prevalence, and long-term prognosis of RIS, as well as the role of disease-modifying therapy should be established in the future.
Demyelinating Diseases
;
Humans
;
Incidence
;
Korea
;
Magnetic Resonance Imaging
;
Multiple Sclerosis
;
Natural History
;
Neurologic Manifestations
;
Prevalence
;
Prognosis
;
White Matter
6.Classic Kaposi's Sarcoma Associated with Gastric Involvement in a 77-year-old Woman.
Sang Youl YUN ; Min Woo PARK ; Moo Kyu SUH ; Jong Im LEE
Korean Journal of Dermatology 2017;55(6):378-380
No abstract available.
Aged*
;
Female
;
Humans
;
Sarcoma, Kaposi*
7.Classic Kaposi's Sarcoma Associated with Gastric Involvement in a 77-year-old Woman.
Sang Youl YUN ; Min Woo PARK ; Moo Kyu SUH ; Jong Im LEE
Korean Journal of Dermatology 2017;55(6):378-380
No abstract available.
Aged*
;
Female
;
Humans
;
Sarcoma, Kaposi*
8.Kerion Celsi Caused by Trichophyton rubrum in an Elderly.
Sang Youl YUN ; Min Woo PARK ; Moo Kyu SUH ; Gyoung Yim HA ; Jong Im LEE ; Jong Soo CHOI
Korean Journal of Medical Mycology 2016;21(3):92-97
Kerion celsi is a severe inflammatory type of tinea capitis that presents as a boggy mass studded with broken hairs, oozing purulent material from follicular orifices. This infection is caused most commonly by zoophilic or geophilic pathogens. Trichophyton(T.) rubrum is an anthropophilic dermatophyte that is found all over the world. It has become one of the most important causative agents in tinea unguium and tinea pedis. But, kerion celsi caused by T. rubrum is rare. Kerion celsi is uncommon in adult. We report a case of kerion celsi caused by T. rubrum in a 72-year-old woman. She presented with localized tender erythematous plaques with pustules with oozing purulent material on the frontal scalp. A fungal culture from tissue of the lesions was grown on Sabouraud's dextrose agar and showed typical whitish cottony colonies of T. rubrum. The nucleotide sequence of internal transcribed spacer region for clinical isolate was identical to that of T. rubrum strain UZ1588_14 (GenBank accession number KP326579.1). She was treated with 200 mg of oral itraconazole daily for 3 months. The skin lesions improved 1 month after treatment, and recurrence has not been observed.
Adult
;
Agar
;
Aged*
;
Arthrodermataceae
;
Base Sequence
;
Female
;
Glucose
;
Hair
;
Humans
;
Itraconazole
;
Onychomycosis
;
Recurrence
;
Scalp
;
Skin
;
Tinea Capitis*
;
Tinea Pedis
;
Trichophyton*
9.Kerion Celsi Caused by Trichophyton verrucosum in an Adult.
Jun Gyu SONG ; Sang Youl YUN ; You Bum SONG ; Moo Kyu SUH ; Gyoung Yim HA ; Jong Im LEE ; Jong Soo CHOI
Korean Journal of Dermatology 2016;54(4):318-319
No abstract available.
Adult*
;
Humans
;
Tinea Capitis*
;
Trichophyton*
10.Effect of the Ethanol Extract of Propolis on Formation of Streptococcus mutans Biofilm.
Bog Im PARK ; Yeon Woo JUNG ; Young Hoi KIM ; Sang Moo LEE ; Lee Seong KWON ; Kang Ju KIM ; So Youn AN ; Na Young CHOI ; Yong Ouk YOU
International Journal of Oral Biology 2016;41(4):253-262
Streptococcus mutans (S. mutans) is one of the most important bacteria in the formation of dental plaque and dental caries. S. mutans adheres to an acquired pellicle formed on the tooth surface, and aggregates with many oral bacteria. It initiates plaque formation by synthesizing glucan from sucrose, which is catalyzed by glucosyltransferases. Propolis is a resinous mixture produced by honeybees, by mixing saliva and beeswax with secretions gathered from wood sap and flower pollen. Bees prevent pathogenic invasions by coating the propolis to the outer and inner surface of the honeycomb. Propolis has traditionally been used for the treatment of allergic rhinitis, asthma and dermatitis. We investigated the inhibitory effects of propolis ethanol extract on biofilm formation and gene expression of S. mutans. The biofilm formation of S. mutans was determined by scanning electron microscopy (SEM) and safranin staining. We observed that the extract of propolis had an inhibitory effect on the formation of S. mutans biofilms at concentrations higher than 0.2 mg/ml. Real-time PCR analysis showed that the gene expression of biofilm formation, such as gbpB, spaP, brpA, relA and vicR of S. mutans, was significantly decreased in a dose dependent manner. The ethanol extract of propolis showed concentration dependent growth inhibition of S. mutans, and significant inhibition of acid production at concentrations of 0.025, 0.05, 0.1 and 0.2 mg/ml, compared to the control group. These results suggest that the ethanol extract of propolis inhibits gene expression related to biofilm formation in S. mutans
Asthma
;
Bacteria
;
Bees
;
Biofilms*
;
Dental Caries
;
Dental Plaque
;
Dermatitis
;
Ethanol*
;
Flowers
;
Gene Expression
;
Glucosyltransferases
;
Microscopy, Electron, Scanning
;
Pollen
;
Propolis*
;
Real-Time Polymerase Chain Reaction
;
Rhinitis, Allergic
;
Saliva
;
Streptococcus mutans*
;
Streptococcus*
;
Sucrose
;
Tooth
;
Wood

Result Analysis
Print
Save
E-mail